Top Clinical Trials companies in Italy by Net Income Margin

This ranking features the top 2 Clinical Trials companies in Italy ranked by Net Income Margin, averaging a Net Income Margin of -102.88%, for February 08, 2025.

Italy

Clinical Trials
Net Income Margin
#
Name
Net Income Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
PHIL.MI

Philogen S.p.A.

1

PHIL.MI
-26.64%
Dec. 31, 2023 USD 19.11 -0.17%

Italy
2
NP5.DE

Newron Pharmaceuticals S.p.A.

2

NP5.DE
-179.13%
Dec. 31, 2023 USD 10.99 1.17%

Italy
Frequently Asked Questions
  • Which Clinical Trials company in Italy has the highest Net Income Margin ?

    The Clinical Trials company in Italy with the highest Net Income Margin is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at -26.64%.

  • Which Clinical Trials company in Italy has the lowest Net Income Margin ?

    The Clinical Trials company in Italy with the lowest Net Income Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -179.13%.

SV Wall Street